Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Stephenson says homophobia among gay men raises risk of intimate partner violence

Frey says having more immigrants with higher birth rates fills need in the US

Inglehart's work on the rise of populism cited in NYT

More News

Highlights

Savolainen wins Outstanding Contribution Award for study of how employment affects recidivism among past criminal offenders

Giving Blueday at ISR focuses on investing in the next generation of social scientists

Pfeffer and Schoeni cover the economic and social dimensions of wealth inequality in this special issue

PRB Policy Communication Training Program for PhD students in demography, reproductive health, population health

More Highlights

Next Brown Bag

Mon, Jan 23, 2017 at noon:
H. Luke Shaefer

Prevalence of cognitive impairment without dementia in the United States

Publication Abstract

Plassman, B.L., Kenneth M. Langa, G.G. Fisher, Steven Heeringa, David Weir, Mary Beth Ofstedal, J.R. Burke, M.D. Hurd, G.G. Potter, Willard Rodgers, D.C. Steffens, J.J. McArdle, Robert Willis, and R.B. Wallace. 2008. "Prevalence of cognitive impairment without dementia in the United States." Annals of Internal Medicine, 148(6): 427-434.

Cognitive impairment without dementia is associated with increased risk for disability, increased health care costs, and progression to dementia. This study estimates the prevalence of cognitive impairment without dementia in the United States and determines longitudinal cognitive and mortality outcomes. Estimates are derived from participants in the ADAMS (Aging, Demographics, and Memory Study) who were age 71 years or older drawn from the nationally representative HRS (Health and Retirement Study). Assessments included neuropsychological testing, neurologic examination, and clinical and medical history. National prevalence rates were estimated by using a population-weighted sample. Results: In 2002, an estimated 5.4 million people (22.2%) in the United States age 71 years or older had cognitive impairment without dementia. Prominent subtypes included prodromal Alzheimer disease (8.2%) and cerebrovascular disease (5.7%). Among participants who completed follow-up assessments, 11.7% with cognitive impairment without dementia progressed to dementia annually, whereas those with subtypes of prodromal Alzheimer disease and stroke progressed at annual rates of 17% to 20%.

PMCID: PMC2670458. (Pub Med Central)

Browse | Search : All Pubs | Next